None listed
Conditions
Brief summary
This trial is hoping to find out if a new type of antibacterial-coated stitch will help to reduce the risk of infection in the wound after Caesarean Section delivery. At the time of Caesarean Section we will pick, by chance, half of the women in the study to receive the coated stitch in place of the routine non-antibacterial stitch when closing the skin and deeper layers but not the uterus (womb). All other aspects of the care relating to the Caesarean Section will remain unchanged. The follow-up and post-operative care will remain as standard. 30 days after the operation we will collect information from the patient’s midwife/LMC about whether she has had any signs or symptoms that might suggest infection in the wound. Treatment of any infection will not be altered or delayed because of the trial. We will use this information to find out if the antibacterial stitch reduces the risk of infection for women after Caesarean Section. We hypothosise that the antibacterial stitch will reduce the occurance of wound infection.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Elective, semi-elective and emergency caesarean sections in women seen and consented in an Antenatal Clinic or Antenatal Ward setting prior to presentation on the day of surgery. (E.g. including women undergoing emergency caesarean section during attempted vaginal birth after previous caesarean section if seen and consented in antenatal clinic on a prior occasion).
Exclusion criteria
Pre-existing Type 1 or 2 Diabetes (not Gestational diabetes which should resolve post-delivery and remove the increased risk of infection post-operatively).